ICYMI: Shutterfly Downgrade, BioBlast Price Action, Blockchain ETFs
In case you missed it, here are some of Benzinga's top stories from Wednesday, Jan. 17, 2018.
Blockchain ETFs’ Inaugural Trading Session
Wayne Duggan breaks down the arrival of new ETFs - Reality Shares Nasdaq NextGen Economy ETF (NASDAQ: BLCN) and Amplify Transformational Data Sharing ETF (NYSE: BLOK) - dedicated to the new technology that’s been the talk of Wall Street lately. Read “First Blockchain ETFs Debut: Here's What You Need To Know.”
BioBlast Price Action A Mystery To Its CEO
In an exclusive statement to Benzinga, BioBlast Pharma Ltd (NASDAQ: ORPN) CEO Fred Price said the company has “no clue” why its stock has seen such volatility of late. Read more about Wednesday’s price action and Price’s befuddlement in Bill Haddad’s “BioBlast CEO Calls Price Spike 'Bizarre.'”
Shutterfly Downgraded On Valuation
Elizabeth Balboa explains the new bear thesis on Shutterfly, Inc (NASDAQ: SFLY) from Goldman Sachs analyst Christopher Merwin, in “Time To Take Profits In Shutterfly? Goldman Sachs Downgrades.”
See more from Benzinga
ICYMI: Crypto Crackdown, MoviePass, Greenlight Capital, And Under Armour
ICYMI: Snap Sinks, Bitcoin Trust Splits, Facebook's Facelift, Intel's 'Processor-Gate'
© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
